In Vitro And Ex Vivo Relaxometric Properties Of Ethylene Glycol Coated Gadolinium Oxide Nanoparticles For Potential Use As Contrast Agents In Magnetic Resonance Imaging

Magnetic nanoparticles (MNPs) have widely demonstrated their applicability in many biomedical applications including magnetic resonance imaging (MRI), hyperthermia, and drug delivery. However, the effectiveness of MNPs can be limited for in vivo applications due to their hydrophobic surfaces leading to nanoparticle agglomeration and thus requires appropriate surface modification to enhance colloidal stability. Glycols are widely used coating material for surface modifications of MNPs to improve their physicochemical properties and biocompatibility. The present work reports the preparation of two different sized ethylene glycol coated gadolinium oxide nanoparticles (EG@Gd2O3 NPs) using two different synthesis approaches and their applicability as contrast agents in MRI. Thermo-gravimetric analysis and Fourier transform infrared spectroscopy confirmed the successful coating of ethylene glycol on the surface of NPs. We found that independent of the size of NPs, the globular shaped EG@Gd2O3 NPs exhibited similar crystal structures, magnetic properties, and cellular cytotoxicity behavior. However, a significant impact of size on MRI contrast enhancement properties was seen. It was revealed that the relaxivity of EG@Gd2O3 NPs increases with a decrease in particle size. Small sized EG@Gd2O3 NPs (similar to 12nm) exhibited a high specific in vitro and ex vivo longitudinal relaxivity of 3.7 and 1.5mM(-1)s(-1), respectively, thus clearly elucidating the potential of these NPs for use as local contrast enhancement agents. The present study gives insights into the intrinsic dependence of magnetic resonance contrast effects of NPs on particle size and surface coating layer mass ratio and thus demonstrates the development of efficient magnetic nanoparticles based contrast agents by fine tuning of particle size and surface properties.